Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOTAL: Tibolone vs Activelle in Menopause
NCT00431093Phase 4Completed
- Sponsor
- Organon & Co.
- Start
- Nov 2002
- Primary completion
- Mar 2005
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 4, randomised, double-blind trial of tibolone in menopause (2 arms), sponsored by Organon & Co. Primary endpoint: Vaginal Bleeding Pattern at 48 weeks. Started Nov 2002; status: completed.
02
Drugs
tibolone
03
Conditions
menopause
Beyond the preview
Go deeper on NCT00431093.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431093.